Iowa Bill to Double Medical Cannabis Dispensaries Awaits Governor

Iowa’s medical cannabis patients currently have five dispensaries to choose from across the entire state — a number set by the legislature and unchanged since the program began dispensary sales in December 2018. For a patient in Iowa City, there’s a location nearby. For someone in Mason City, Ottumwa, or rural Warren County, the nearest option might mean two hours of driving each way. A bill now before Governor Kim Reynolds would raise that statutory ceiling to ten, the most significant geographic expansion the state’s Medical Cannabidiol Program has seen since it launched.

Reynolds can sign the legislation, allow it to take effect without her signature, or veto it. The Iowa House approved the bill on April 17, 2025, in a near-unanimous 90-2 vote; the Iowa Senate cleared it earlier this year. No public statement from Reynolds’s office has indicated where she stands.

What the Bill Would Do

The legislation’s central change is a statutory amendment to the dispensary cap — raising it from five licensed dispensaries to ten. Under Iowa’s medical cannabis law, the legislature sets this ceiling directly, meaning the Bureau of Cannabis Regulation within the Iowa Department of Health and Human Services cannot issue new dispensary licenses beyond the cap without an act of the legislature. That’s what the bill does.

A second provision would open the program to out-of-state residents for the first time. A non-Iowa resident who obtains a certification from an Iowa healthcare practitioner — a physician, physician assistant, or advanced registered nurse practitioner — could formally register with the program. This is not the same as reciprocity. Iowa already gives visiting patients with out-of-state medical cannabis cards limited possession protections, but no purchase rights. The new provision creates a separate registration pathway: patients who seek out an Iowa provider and receive Iowa certification could register and buy products from Iowa dispensaries.

Iowa currently has two licensed manufacturers — Iowa Cannabis Company and Bud & Mary’s — whose operations supply the five dispensary locations: Waterloo, Iowa City, Council Bluffs, Sioux City, and Windsor Heights, in the Des Moines metro. Raising the cap creates legal room for additional sites, but the licensing process would still need to play out. The Bureau of Cannabis Regulation handles that, and no new dispensary opens automatically from a governor’s signature.

Iowa’s Program in Context

Following the federal rescheduling of medical cannabis, which shifted how state programs interact with federal law, Iowa’s remains one of the most constrained in the country. Flower, smoking, and cannabis-infused food products are prohibited. Approved forms are cannabis preparations — oils, capsules, tinctures, topicals, and vaporizable products. Most patients are capped at 4.5 grams of THC per 90-day period, a ceiling that providers can raise only for terminal patients or for established participants whose certifying practitioner determines the standard limit isn’t adequate.

Qualifying conditions include cancer with severe pain or nausea, multiple sclerosis, seizures, HIV/AIDS, ALS, Parkinson’s disease, PTSD, Crohn’s disease, ulcerative colitis, chronic pain, corticobasal degeneration, severe autism, and terminal illness. Patients must annually recertify with a healthcare practitioner, pay a $100 registration fee (reduced to $25 for patients on Medicaid or receiving disability benefits), and purchase only through the licensed dispensary network. Home cultivation is prohibited under any circumstance.

Against that backdrop, the dispensary count carries real weight. The Marijuana Policy Project, which tracks state medical cannabis programs nationally, has argued that the five-dispensary cap creates a structural access problem for rural patients — that people across large portions of Iowa face meaningful travel barriers to access medication they cannot legally obtain any other way. Iowa’s own medical cannabis advisory board made the same point in a 2023 report, formally recommending that the state expand its licensed dispensary count to address geographic gaps.

The near-unanimous legislative margins — 90-2 in the House — reflect a pattern common to constrained medical cannabis programs: there’s rarely organized legislative opposition to patient access measures that don’t expand what’s permitted, just where it’s available.

The Governor’s Call

Reynolds has taken a cautious line on cannabis policy broadly. In June 2025, she vetoed a bill that would have authorized Iowa physicians to prescribe a synthetic form of psilocybin upon federal approval, arguing it ceded state scheduling authority to federal regulators. The dispensary bill is structurally different — it adjusts a capacity limit within an existing statutory framework without creating any new substance classification or raising federal preemption questions.

If she signs or lets the bill take effect, the Bureau of Cannabis Regulation would move through its standard licensing process for new dispensary applicants — background checks, facility review, compliance auditing. That takes time; patients wouldn’t see new locations open overnight even after a signature. If she vetoes, the five-location cap holds until the legislature returns to the question.

For patients already subject to strict product restrictions, THC limits, and annual recertification requirements, the question the bill poses is direct: can they get their medication from more than five locations in a state of more than three million people.